Asbestosis Treatment Market Analysis

  • Report ID: 5726
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Asbestosis Treatment Market Segmentation:

Drugs Segment Analysis 

Based on drugs, the prednisone segment in the asbestosis treatment market is predicted to hold the largest revenue share of about 45% during the forecast period. Prednisone is a synthetic glucocorticoid that is used to suppress inflammation and weaken the immune system. The liver converts the prodrug prednisone into prednisolone, which is the medication's active component. Prednisone has no biological effects before its conversion to prednisolone through hepatic metabolism. Prednisone's use is expected to rise significantly throughout the forecast period as it is an anti-inflammatory that also helps reduce inflammation caused by sickness. 19,898,457 prescriptions were written in the US in 2021.

Route of Administration Segment Analysis 

Based on the route of administration, the inhalation segment in the asbestosis treatment market is estimated to hold the largest revenue share of about 40% during the forecast period. The growth of the segment is because many people favor inhalation to swallowing tablets or pills for delivery. It has long been established that inhaling medication is an efficient way to get medication into the lungs to treat respiratory conditions. Compared to oral pills, inhaled drugs are taken directly into the airways, allowing for a smaller dose to be given and a faster onset of action as well as fewer side effects. It is anticipated that the growing incidence of respiratory conditions such as cystic fibrosis, asthma, and COPD will propel market growth. Asthma impacted almost 25 million Americans in 2021, making up 7.7% of adults and 8.4% of children in the country, according to the Centers for Disease Control and Prevention (CDC).

Our in-depth analysis of the global asbestosis treatment market includes the following segments:

     Type

  • Chrysolite
  • Amosite
  • Crocidolite

     Mechanism of Action

  • Bronchodilators
  • Expectorants
  • Antibiotics
  • Corticosteroids
  • Analgesics

     Drugs

  • Salbutamol
  • Guaifenesin
  • Acetaminophen
  • Prednisone

     Diagnosis

  • Chest X-Ray
  • CT Scan

     Treatment

  • Medication
  • Supplemental Oxygen
  • Surgery

     Route of Administration

  • Oral
  • Inhalation
  • Intravenous

     Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

     End User

  • Hospitals
  • Homecare
  • Speciality Clinics

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of asbestosis treatment is evaluated at USD 1.88 billion.

The global asbestosis treatment market size exceeded USD 1.78 billion in 2025 and is set to register a CAGR of over 6.1%, exceeding USD 3.22 billion revenue by 2035.

North America asbestosis treatment market will dominate around 32% share by 2035, driven by increasing health awareness, early screening efforts, and strong R&D in asbestosis treatments.

Key players in the market include Eli Lilly and Company, Merck and Co Inc., Novartis AG, Bayer AG, Boehringer Ingelheim International GmbH, Johnson & Johnson Private Limited, Squibb Company, Novocure, Bristol-Myers.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos